The Winter Gap: Swiss Electricity Security, the Hormuz Gas Shock and the Value of the Electricity Agreement with the EU
A gas price model and a Monte Carlo winter balance show Swiss net imports of about 2.7 TWh in a normal winter but 8.4 TWh with two reactors offline. With gas near EUR 75, household tariffs could rise by CHF 170 to 280 in 2028. The EU agreement is insurance.
The End of a Ninety-Year Tax: Mortgage Rates, Public Revenue and House Prices After the Abolition of the Imputed Rental Value in 2029
The abolition of the imputed rental value breaks even at an average mortgage rate of 2.83 percent. Simulations of Swiss mortgage rates show a revenue loss of about CHF 1.9 billion a year from 2029 and CHF 13.5 billion by 2035, mostly borne by the cantons.
The Six-Billion Question: SNB Profit Distributions, the Debt Brake and the Covid Debt That Will Not Disappear by 2035
A Monte Carlo model of SNB results under the new 2026 to 2030 agreement gives a 71 percent chance of a CHF 6 billion payout in 2027, but shows the Covid debt cannot be repaid by 2035 with SNB money: even maximum payouts leave CHF 14.6 billion.
The Price of Safety: What the Market, the Balance Sheet and the Public Purse Say About the UBS Capital Rules
An event study of nine regulatory events shows investors took about CHF 11 billion off UBS, implying an annual cost near CHF 0.9 billion. The upper house's 90 percent rule buys 82 percent of the protection of full backing for 84 percent of its cost.
The Second Windfall: Commodity Trading Profits, Geneva’s Public Finances and the Fiscal Echo of the 2026 Oil Shock
Commodity traders earned CHF 74 billion above trend in 2021 to 2024, yielding about CHF 6.4 billion of extra taxes. A record first half of 2026 signals a second windfall of CHF 1 to 3 billion in taxes, due mainly in 2028 and 2029.
The Slow Shield: How the Franc, Taxes and Structure Kept the 2026 Oil Shock out of Swiss Inflation
Brent rose 71 percent in francs between February and September 2026, more than in dollars, yet Swiss inflation barely reached 1 percent. The franc is a slow shield, not a fast one: what kept oil out of Swiss inflation was a small energy weight and core inflation of half a percent. The real risk for the SNB in 2027 is renewed franc strength.
The Golden Distortion: A Gold-Adjusted View of Switzerland’s Trade Balance and Its Quarrel with Washington
Gold trade now exceeds a third of Swiss GDP, explains most quarterly swings in the trade balance and lowered the 2025 current account surplus from 8.4 to 5.6 percent of GDP. Excluding gold helped Switzerland in Washington on 2024 data, but on 2025 data it makes the underlying imbalance look worse.
Exporting the Reference Price: How US Most-Favoured-Nation Drug Pricing Turned Switzerland into America’s Price Anchor
Once prices are adjusted for income, Switzerland has the lowest drug prices in the US most-favoured-nation basket and sets the US price for about 83 percent of new medicines. That explains why a third of new medicines are being withheld from Swiss reimbursement, and what a targeted launch-price uplift would cost premium payers.
The Pharma Mirage: Measuring Swiss Growth When One Industry Writes the Headlines
Chemicals and pharmaceuticals are 7 percent of Swiss GDP but now drive 37 percent of the variance of quarterly growth. Stripping the industry out shows there was no recession in 2025, that real output per head outside pharma grew only 0.3 percent a year over a decade, and that the 2026 recovery rests on foreign rather than domestic demand.
Tariff Whiplash: What Five US Tariff Regimes Reveal About the Swiss Export Model
Between April 2025 and August 2026 Swiss goods faced five different US tariff regimes, from 10 to 39 per cent and back. Using three validated counterfactuals, this paper shows that the tariff rate explains almost none of the export loss. A steady, tariff-insensitive drift does: the signature of production relocating to the United States.